Try our corporate solution for free!
(212) 419-8286

AbbVie: revenue of Humira 2011-2019

This statistic illustrates the revenue of pharmaceutical product Humira from 2011 to 2019. In 2018, AbbVie's top product generated nearly 20 billion U.S. dollars of revenue. Abbot Laboratories was a U.S.-based global pharmaceutical and healthcare products company, headquartered in Chicago, Illinois. In January 2013, Abbott was separated into two companies: Abbott and AbbVie. Abbott is now specialized on medical products, while AbbVie is responsible for research-based pharmaceuticals.

Abbvie's top product Humira

AbbVie’s Humira has increased its revenue from 2011 to 2018, generating 7.9 billion U.S. dollars in 2011 and nearly 20 billion U.S. dollars in 2018. Humira is expected to continue its success in the near future. It is projected to maintain similar high revenues until 2024 worldwide. In the United States, AbbVie expended 410 million U.S. dollars on advertising for Humira in 2017.

Adalimumab is marketed as Humira, a biotech pharmaceutical product. The name “Humira” is derived from “human monoclonal antibody in rheumatoid arthritis”. The inhibiting anti-inflammatory drug acts by inhibiting the activation of tumor necrosis factor-alpha (TNF) which can downregulate inflammation caused by autoimmune diseases. For example, it can be used for rheumatoid arthiritis which attacks the joints and can also impact tissues and organs. Humira can be also be used for diseases such as Plaque psoriasis and Crohn’s disease. Prices of for two kits of Humira Pen (40 mg) in the U.S. on averagecost some 4,500 U.S. dollars, as of 2017.

AbbVie's revenue from top product Humira from 2011 to 2019

Exclusive Premium statistic

You need a Single Account for unlimited access.

  • Full access to 1m statistics

  • Incl. source references

  • Available to download in PNG, PDF, XLS format

Single Account

$39 $59 per month *
in the first 12 months
33% discount until March 31st
*Duration: 12 months, billed annually, single license

Access to this and all other statistics on 80,000 topics from

$468 / Year
$708 / Year

Show detailed source information?
Register for free
Already a member?
Log in

Release date




Survey time period

2011 to 2019

Supplementary notes

* Added from previous annual reports.

Open this statistic in...
Statista Accounts: Access All Statistics. Starting from $468 / Year
Basic Account
Get to know the platform

You only have access to basic statistics.
This statistic is not included in your account.

Single Account
The ideal entry-level account for individual users
  • Instant access to 1m statistics
  • Download in XLS, PDF & PNG format
  • Detailed references
$59 $39 / Month *
in the first 12 months
Corporate Account
Full access

Corporate solution including all features.

* Prices do not include sales tax.

Statistics on "Pharmaceutical brands: Humira (AbbVie)"

Statista Accounts: Access All Statistics. Starting from $468 / Year
Learn more about how Statista can support your business.